Skip to the page

Data / Form D filings / CAPRICOR THERAPEUTICS, INC.

CAPRICOR THERAPEUTICS, INC.: Form D filings

CAPRICOR THERAPEUTICS, INC., a biotechnology company in Beverly Hills, CA, filed 8 Form D notices with the SEC between 2009 and 2017. The latest, on May 19, 2017, reports $3.7 million sold of a $3.7 million offering to 4 investors.

Find out what CAPRICOR THERAPEUTICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8840 WILSHIRE BLVD 2ND FLOOR, Beverly Hills, CA, 90211
Phone
(310) 358-3200
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1133869

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 19, 2017New notice$3,708,503$3,708,503$04May 9, 2017sec.gov
Mar 29, 2016New notice$13,974$13,974$024Mar 16, 2016sec.gov
Feb 19, 2015New notice$7,050,001$7,050,001$08Feb 6, 2015sec.gov
Feb 3, 2015New notice$10,002,028$10,002,028$039Jan 21, 2015sec.gov
Feb 24, 2014New notice$32,676$32,676$01Feb 10, 2014sec.gov
Dec 5, 2013New notice$26,289,973$26,289,973$034Nov 20, 2013sec.gov
Jun 27, 2011New notice$2,500,000$2,500,000$06Jun 20, 2011sec.gov
Jul 15, 2009New notice$2,975,000$2,343,750$631,25024Jul 7, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Frank LitvackDirector
Deborah AscheimExecutive Officer
Leland GershellExecutive Officer
Earl CollierDirector
Joshua KazamDirector
Louis ManzoDirector
Rachel SmithExecutive Officer
Karen KrasneyExecutive Officer
Linda MarbanExecutive Officer, Director
David MusketDirector
George DunbarDirector
Anthony BergmannExecutive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of May 15, 2017 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CAPRICOR THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.